More than a billion COVID-19 vaccine doses administered globally

Multiple billion doses of coronavirus vaccines have been administered worldwide, less than five months after the first mass inoculation programs started out to be rolled out, according to an AFP tally at 17:45 GMT on Saturday.

At least 1,002,938,540 doses have been administered in 207 countries and territories, based on the tally compiled from official sources.

Over fifty percent, or 58 percent, have already been given in three countries: america with 225.6 million doses, China with 216.1 million doses and India with 138.4 million.

However, regarding the proportion of the population who've been vaccinated, Israel is in the lead, with almost six from every 10 Israelis fully inoculated.

That is followed by the United Arab Emirates with an increase of than 51 percent of the populace has received at least one jab, Britain with 49 percent, the U.S. with 42 percent, Chile with 41 percent, Bahrain with 38 percent and Uruguay with 32 percent.

In the EU, 128 million doses have already been administered to 21 percent of the populace. Malta is at the forefront in the 27-nation bloc, with 47 percent of its population inoculated and Hungary with 37 percent. But in Germany, only 22.6 percent of the populace have already been vaccinated, 22.3 percent in Spain, 20.5 percent in France and 19.9 percent in Italy.

Worldwide, the number of vaccine doses administered has doubled in less than per month as inoculation programs pick up speed.

While the majority of poor countries also have started to vaccinate, mainly because of the Covax program, inoculation is still largely a privilege of high-income countries, as defined by the World Bank, which are home to 16 percent of the world's population but have administered 47 percent of vaccine doses.

Low-income countries take into account just 0.2 percent of doses administered.

Some 12 countries have still to get started vaccinating -- seven in Africa (Tanzania, Madagascar, Burkina Faso, Chad, Burundi, Central African Republic and Eritrea; three in Oceania (Vanuatu, Samoa and Kiribati; one in Asia (North Korea); and one in the Caribbean (Haiti).

Despite the troubles which has plagued it since it was approved for use, the jab produced by AstraZeneca and Oxford University may be the most widely used up to now, and has been administered in three-quarters or 156 of these countries and territories that have started vaccinating.

A rival jab produced by Pfizer and BioNTech has been administered in 91 countries, or 44 percent of the total. Another shot produced by Moderna has been administered in 46 countries or 22 percent. Sinopharm's jab has been administered in at elast 41 countries or 20 percent of the total, Sputnik V in at least 32 countries or 15 percent, and Sinovac in at least 21 or ten percent.